Evidence map›Paper›PMID 14064818›Full record

ArticleActa pathologica et microbiologica Scandinavica1963

A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

K BERG

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Acta pathologica et microbiologica Scandinavica, 1963. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04613167 (Genetic, Biochemical and Functional Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment Options), which is not on this map. Cited by 285 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
285citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04613167 naunknown statusstarted 2020, after this paper: background citation

Genetic, Biochemical and Functional Markers of Cardiovascular Risk in Patients With Premature Coronary Artery Disease and Treatment Options

Ran2020Enrolled70Registered outcomes3Posted comparisons0ConditionsAcute Coronary Syndrome, Genetic Polymorphisms, Inflammation, LipoproteinemiaArmsAlirocumab, Control group, Evolocumab
PMID 30995439PMID 30838555PMID 31061262PMID 32453609PMID 20032323PMID 10510054PMID 18775538PMID 19124843PMID 19622820PMID 23594558PMID 25120086PMID 26002446other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

285 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Cytosine base editing of LPA in transgenic mice averts large deletions.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  18. The Emerging Lipid Risk: Lipoprotein(a).Korean circulation journal · 2026
    Review
  19. Review
  20. Article

225 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

K BERG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood Group AntigensBlood ProteinsImmune SeraImmunodiffusionImmunoelectrophoresisLipoproteinsPrecipitin TestsAnimalsHumansMaleRabbitsBlood Group AntigensBlood ProteinsImmune SeraLipoproteinsBLOOD GROUPSBLOOD PROTEINSGEL DIFFUSION TESTSIMMUNE SERUMSIMMUNOELECTROPHORESISLIPOPROTEINSPRECIPITIN TESTSRABBITS

Identifiers

PMID14064818

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.